Top Clinical Trials companies in the world by Total Assets

This ranking features the top 278 Clinical Trials companies in the world ranked by Total Assets, totalling a Total Assets of USD 191.30 B, for January 15, 2025.

Global

Clinical Trials

#	Name	Total Assets	Reported Date	Stock Price	Change	Country
1	BioNTech SE 1 22UA.F	USD 25.39 B	Dec. 31, 2023	USD 116.36	-0.45%	Germany
2	Vertex Pharmaceuticals Incorporated 2 VRTX	USD 22.73 B	Dec. 31, 2023	USD 411.66	-0.41%	United States
3	ICON Public Limited Company 3 ICLR	USD 16.99 B	Dec. 31, 2023	USD 200.24	-8.14%	Ireland
4	Charles River Laboratories International, Inc. 4 CRL	USD 8.20 B	Dec. 30, 2023	USD 178.08	-6.34%	United States
5	Incyte Corporation 5 INCY	USD 6.78 B	Dec. 31, 2023	USD 71.93	-0.61%	United States
6	Genmab A/S 6 GMAB.CO	USD 5.22 B	Dec. 31, 2023	USD 216.88	1.28%	Denmark
7	Hangzhou Tigermed Consulting Co., Ltd. 7 3347.HK	USD 4.18 B	Dec. 31, 2023	USD 3.72	2.09%	China
8	Alnylam Pharmaceuticals, Inc. 8 ALNY	USD 3.83 B	Dec. 31, 2023	USD 240.51	-6.88%	United States
9	Sarepta Therapeutics, Inc. 9 SRPT	USD 3.26 B	Dec. 31, 2023	USD 118.83	0.34%	United States
10	Neurocrine Biosciences, Inc. 10 NBIX	USD 3.25 B	Dec. 31, 2023	USD 139.51	-2.46%	United States
11	Exelixis, Inc. 11 EXEL	USD 2.94 B	Dec. 29, 2023	USD 35.65	0.99%	United States
12	Revolution Medicines, Inc. 12 RVMD	USD 2.06 B	Dec. 31, 2023	USD 39.83	-6.44%	United States
13	Legend Biotech Corporation 13 LEGN	USD 1.85 B	Dec. 31, 2023	USD 31.64	-2.65%	United States
14	Guardant Health, Inc. 14 GH	USD 1.79 B	Dec. 31, 2023	USD 37.46	-1.68%	United States
15	NeoGenomics, Inc. 15 NEO	USD 1.68 B	Dec. 31, 2023	USD 13.78	9.11%	United States
16	Medpace Holdings, Inc. 16 MEDP	USD 1.66 B	Dec. 31, 2023	USD 330.91	-5.99%	United States
17	Joinn Laboratories(China)Co.,Ltd. 17 6127.HK	USD 1.41 B	Dec. 31, 2023	USD 1.06	2.98%	China
18	InnoCare Pharma Limited 18 9969.HK	USD 1.40 B	Dec. 31, 2023	USD 0.69	3.45%	China
19	Shanghai Henlius Biotech, Inc. 19 2696.HK	USD 1.39 B	Dec. 31, 2023	USD 2.59	-10.24%	China
20	Intellia Therapeutics, Inc. 20 NTLA	USD 1.30 B	Dec. 31, 2023	USD 9.74	-3.08%	United States
21	Akeso, Inc. 21 9926.HK	USD 1.29 B	Dec. 31, 2023	USD 7.28	2.32%	China
22	HUTCHMED (China) Limited 22 0013.HK	USD 1.28 B	Dec. 31, 2023	USD 3.02	2.59%	Hong Kong
23	Supernus Pharmaceuticals, Inc. 23 SUPN	USD 1.28 B	Dec. 31, 2023	USD 37.82	0.66%	United States
24	Denali Therapeutics Inc. 24 DNLI	USD 1.15 B	Dec. 31, 2023	USD 18.74	-4.34%	United States
25	Arrowhead Pharmaceuticals, Inc. 25 ARWR	USD 1.14 B	Sept. 30, 2024	USD 18.05	-4.55%	United States
26	Arcus Biosciences, Inc. 26 RCUS	USD 1.09 B	Dec. 31, 2023	USD 13.82	-0.79%	United States
27	Blueprint Medicines Corporation 27 BPMC	USD 1.05 B	Dec. 31, 2023	USD 102.56	-0.77%	United States
28	Zai Lab Limited 28 9688.HK	USD 1.04 B	Dec. 31, 2023	USD 2.49	0.18%	China
29	Xenon Pharmaceuticals Inc. 29 XENE	USD 964.80 M	Dec. 31, 2023	USD 39.65	3.66%	Canada
30	Xencor, Inc. 30 XNCR	USD 952.69 M	Dec. 31, 2023	USD 19.11	-5.68%	United States
31	CureVac N.V. 31 5CV.F	USD 870.03 M	Dec. 31, 2023	USD 3.95	-0.95%	Germany
32	Relay Therapeutics, Inc. 32 RLAY	USD 843.98 M	Dec. 31, 2023	USD 4.35	-9.00%	United States
33	uniQure N.V. 33 QURE	USD 831.69 M	Dec. 31, 2023	USD 13.23	-4.06%	Netherlands
34	Arcellx, Inc. 34 ACLX	USD 825.13 M	Dec. 31, 2023	USD 64.65	-4.02%	United States
35	Cytokinetics, Incorporated 35 CYTK	USD 824.32 M	Dec. 31, 2023	USD 45.23	-3.17%	United States
36	Krystal Biotech, Inc. 36 KRYS	USD 818.36 M	Dec. 31, 2023	USD 142.64	-5.10%	United States
37	Travere Therapeutics, Inc. 37 TVTX	USD 788.91 M	Dec. 31, 2023	USD 17.07	-8.18%	United States
38	RemeGen Co., Ltd. 38 9995.HK	USD 778.65 M	Dec. 31, 2023	USD 1.59	2.46%	China
39	Verve Therapeutics, Inc. 39 VERV	USD 752.69 M	Dec. 31, 2023	USD 5.25	-4.54%	United States
40	Intra-Cellular Therapies, Inc. 40 ITCI	USD 728.29 M	Dec. 31, 2023	USD 126.89	-0.24%	United States
41	SpringWorks Therapeutics, Inc. 41 SWTX	USD 725.79 M	Dec. 31, 2023	USD 32.50	-12.19%	United States
42	Prothena Corporation plc 42 PRTA	USD 696.38 M	Dec. 31, 2023	USD 12.67	-3.50%	Ireland
43	PureTech Health plc 43 PRTC.L	USD 693.97 M	Dec. 31, 2023	USD 1.72	1.09%	United States
44	iTeos Therapeutics, Inc. 44 ITOS	USD 667.59 M	Dec. 31, 2023	USD 7.66	-1.80%	United States
45	Adaptive Biotechnologies Corporation 45 ADPT	USD 661.13 M	Dec. 31, 2023	USD 6.07	-6.04%	United States
46	Mirum Pharmaceuticals, Inc. 46 MIRM	USD 646.62 M	Dec. 31, 2023	USD 43.32	-1.54%	United States
47	Allogene Therapeutics, Inc. 47 ALLO	USD 642.84 M	Dec. 31, 2023	USD 1.92	-1.54%	United States
48	Crinetics Pharmaceuticals, Inc. 48 CRNX	USD 635.35 M	Dec. 31, 2023	USD 35.62	-8.62%	United States
49	Avidity Biosciences, Inc. 49 RNA	USD 628.55 M	Dec. 31, 2023	USD 27.05	-4.79%	United States
50	Alector, Inc. 50 ALEC	USD 621.83 M	Dec. 31, 2023	USD 1.64	-8.38%	United States

1 2 3 4 5 6

Frequently Asked Questions

Which Clinical Trials company has the highest Total Assets ?

The Clinical Trials company with the highest Total Assets is BioNTech SE (Frankfurt Stock Exchange: 22UA.F) at USD 25.39 B.
Which Clinical Trials company has the lowest Total Assets ?

The Clinical Trials company with the lowest Total Assets is Prostatype Genomics AB (publ) (Stockholm Stock Exchange: PROGEN.ST) at USD 4.86 M.

What are the top 10 Clinical Trials companies by Total Assets ?

The top 10 Clinical Trials companies the Global by Total Assets are BioNTech SE, Vertex Pharmaceuticals Incorporated, ICON Public Limited Company, Charles River Laboratories International, Inc., Incyte Corporation, Genmab A/S, Hangzhou Tigermed Consulting Co., Ltd., Alnylam Pharmaceuticals, Inc., Sarepta Therapeutics, Inc. and Neurocrine Biosciences, Inc..
What are the bottom 10 Clinical Trials companies by Total Assets ?

The bottom 10 Clinical Trials companies by Total Assets are Prostatype Genomics AB (publ), GENinCode plc, XORTX Therapeutics Inc., Clinical Laserthermia Systems AB (publ), OncoTherapy Science, Inc., Saniona AB (publ), Edesa Biotech, Inc., Calidi Biotherapeutics, Inc., Vivos Therapeutics, Inc. and vTv Therapeutics Inc..